 Diversified Trust Co bought a new stake in Aimmune Therapeutics Inc NASDAQ:AIMT in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission SEC. The firm bought 20,000 shares of the biotechnology companys stock, valued at approximately 288,000. A number of other institutional investors have also recently bought and sold ... 